Bioventix confirms an interim dividend of 70p per share. The shares will be marked ex-dividend on the 9th April 2026 and the dividend will be paid on 24th April 2026 to shareholders on the register at close of business on 10th April 2026.
Other Financial Highlights:
- Revenue of £6.16 million (2024: £6.73 million)
- Profit before tax of £4.85 million (2024: £5.05 million)
- Revenue of £6.4 million with PBT of £5.1 million on constant currency basis (at average exchange rates for 2024)
- Closing cash balances of £5.3 million (2024 £5.1 million)
- Interim dividend 70p (2024: 70p)
- Tau/neuro royalties increased five-fold to £150k (2024: £30k)
- Bioventix SMAs now included in the design of multiple research use only assays for Alzheimer's disease,
- Trading remains in line with expectations for the year ending 30 June 2026
